Physician

Seung Lee, M.D.

According to 2025 Medicare claims, Seung Lee, M.D. (NPI: 1750313011) practices otolaryngology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is HAWAII EAR NOSE AND THROAT CONSULTANTS CORP (NPI: 1154350148; TIN: 204330260) and primary practice location at 96701-5311.

Lee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 834 traditional Medicare patients, billed 3,982 HCPCS/CPT codes, and received $427,445 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 734 prescription claims across 334 beneficiaries totaling $33,916 in drug costs, led by Fluticasone Propionate (Fluticasone Propionate). DME data shows 21 claims. Open Payments data shows 16 records totaling $84,039. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $375,999 to $427,445. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,938 and ending at $2,863.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,055	4,578	$375,999
2016	970	4,127	$349,299
2017	967	4,303	$365,403
2018	1,060	4,647	$393,601
2019	1,056	4,857	$463,241
2020	974	5,254	$539,815
2021	1,030	5,741	$703,394
2022	945	4,650	$583,350
2023	796	3,823	$557,441
2024	834	3,982	$427,445

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	353	1,057	$44,551
2016	320	1,034	$42,648
2017	386	1,098	$52,444
2018	409	1,089	$47,473
2019	399	972	$64,544
2020	416	960	$51,467
2021	374	793	$31,515
2022	375	788	$32,019
2023	353	773	$28,790
2024	334	734	$33,916

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$771
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	29	$828
2022	N/R	11	$281
2023	N/R	24	$1,019
2024	N/R	21	$598

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	652	1,103	$144
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	191	261	$125
31575	Diagnostic exam of voice box using a flexible endoscope	205	274	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	618	1,006	$61
92588	Placement of ear probe for computerized measurement of repeated sounds with interpretation and report	165	167	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluticasone Propionate	Fluticasone Propionate	327	27,200	$8,508
Azelastine Hcl	Azelastine Hcl	113	6,834	$7,370
Mometasone Furoate	Mometasone Furoate	14	870	$2,937
Azelastine-Fluticasone	Azelastine/Fluticasone	13	870	$2,043
Ofloxacin	Ofloxacin	29	509	$1,621

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	21	$598

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$559	Stryker Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$83,480	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Seung Lee, M.D.?

Tedicare shows public-source Medicare data for Seung Lee, M.D. (NPI 1750313011), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Seung Lee, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Seung Lee, M.D.?

Seung Lee, M.D. is linked to HAWAII EAR NOSE AND THROAT CONSULTANTS CORP (billing NPI 1154350148) in the available physician profile data.

Does Seung Lee, M.D. have Open Payments data?

Seung Lee, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.